October 6, 2016 — Federal judges have centralized dozens of Taxotere lawsuits involving permanent hair loss in a Multi-District Litigation (MDL No. 2740) under one judge in Louisiana.
The U.S. Judicial Panel on Multidistrict Litigation issued an order (PDF) on October 3, transferring 89 lawsuits in dozens of districts nationwide into the U.S. District Court for the Eastern District of Louisiana.
The MDL will be overseen by U.S. District Judge Lance M. Africk, who has not yet had the opportunity to preside of an MDL.
When lawyers requested the MDL in July, there were 33 lawsuits in 16 district courts. Since then, 56 lawsuits have been filed in 25 districts.
All of the lawsuits were filed by people who experienced permanent hair loss (alopecia) after Taxotere was used in their chemotherapy treatment. Lawyers say Sanofi-Aventis knew about the risk and failed to issue warnings until December 2015.
Sanofi-Aventis is also accused of marketing Taxotere as superior to other, equally-effective chemotherapy drugs that were not associated with permanent hair loss.
All of the parties supported centralizing the lawsuits in an MDL but disagreed on the venue. The judges said there was no clear focal point because the lawsuits were so widely-dispersed. The Eastern District of Louisiana was chosen because 10 cases are pending there.
Do I have a Taxotere Lawsuit?
The Schmidt Firm, PLLC is currently accepting Taxotere induced injury cases in all 50 states. If you or somebody you know has been diagnosed with permanent hair loss, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.